Yet again. The United States government’s Food and Drug Administration (FDA) this week warned of a danger — this time the bleeding disorder immune thrombocytopenia — from Johnson & Johnson’s experimental coronavirus vaccine shot, while, as usual, remaining silent about dangers from competing shots from Moderna and Pfizer-BioNTech.
Tag: Pfizer-BioNTech
Children have virtually no risk of major sickness or death from coronavirus. And experimental coronavirus “vaccines” such as the one produced by the Pfizer and BioNTech do come with major known health risks of their own. Additional potential side effects of these companies’ and other companies’ shots remain unknown given the shots’ unusually rushed rollout.
Nevertheless, on Thursday, Pfizer and BioNTech sought approval from the United States Food and Drug Administration (FDA) for giving their experimental coronavirus vaccine, which is not even a vaccine under the normal meaning of the term, to children ages five through 11. (Approval is already in place for ages 12 and up.) With the Biden administration, from Joe Biden on down, pushing for everyone — including younger children as soon as legally allowed — to receive experimental coronavirus vaccine shots, there will be much pressure on people in the FDA to give an OK to Pfizer and BioNTech’s request.
Much attention is focused on President Joe Biden in a Thursday speech announcing that the coronavirus testing alternative United States government employees had been able to use to avoid the mandate to take experimental coronavirus vaccines is being eliminated and that regulations are in the works to require all employees at companies with 100 or more employees to take the “vaccines” or be tested weekly. Less noticed is news that experimental coronavirus vaccines may soon be rolled out for young children. Pfizer-BioNTech is seeking in the next few weeks approval for giving its experimental coronavirus vaccine shots to children ages five through 11, while Moderna is close behind, proceeding with testing of its shots on children 11 and younger. Then come shots for toddlers and babies.
Shots mandates for workers first, shots mandates for children next: That seems to be the situation in America, though it should be noted that some children —especially older children — are workers too.
Categories
Ineffective Coronavirus Vaccine
On Thursday, United States President Joe Biden was hyping the supposed effectiveness of experimental coronavirus vaccine shots. He claimed in a CNN event that people who take the shots will not “get covid,” “be hospitalized,” “be in an ICU unit,” or “die.” It turns out Biden’s assurance is wrong.
The experimental coronavirus vaccines, some of which are not even vaccines under the normal meaning of the term, are not miracle drugs. Indeed, recent information from Israel, where shots were given very widely and early, indicates that whatever effectiveness the shots may have in countering coronavirus appears to wear off mighty quickly.
In May, when experimental Pfizer-BioNTech coronavirus “vaccine” shots were being rolled out for children ages 12 to 15, I wrote that state and local governments should decline to participate in the promotion and distribution of these shots to children. What is the sense in subjecting kids to known risks of the shots, as well as risks that in part due to the rushed introduction of the shots are still unknown, in response to coronavirus that poses near zero risk of death or severe illness to them? Governments, leave the kids alone.
It does not seem fair. This week, Johnson & Johnson was called out by the Food and Drug Administration (FDA) for problems with Johnson & Johnson’s experimental coronavirus vaccine. While experimental coronavirus vaccine competitors Moderna and Pfizer-BioNTech skated by without censure despite their shots appearing likely to cause the same problems, the FDA put out a warning regarding the Johnson & Johnson shot.
This week, some state and local governments in America are expected to begin working with the United States government on giving shots of Pfizer-BioNTech’s experimental coronavirus “vaccine” to 12 to 15 years old children. This shot-giving will supplement the major push for giving experimental coronavirus shots, made by several manufacturers, to Americans 16 and older that has been going on for several months.
Will some state and local governments refuse to participate in this expansion of the program? If they support children’s health, they should say no.
When the United States government’s Food and Drug Administration earlier this week called for temporarily halting the giving of Johnson & Johnson’s experimental coronavirus vaccine shots because of the developing of blood clots in people who have received the shots, I asked if we were seeing an example of regulatory favoritism for the new mRNA technology shots over more traditional vaccine shots such as the Johnson & Johnson shots. The question arises because the US government is still encouraging everyone to take experimental mRNA “vaccines” from Moderna and Pfizer-BioNTech regarding which there are also many reports of injury and death.
While a variety or injuries and deaths have been reported after people have taken experimental coronavirus vaccine shots developed respectively by the three companies, if you focus in on just blood clot problems, those problems appear to arise after Moderna and Pfizer-BioNTech experimental coronavirus shots as well as after Johnson & Johnson shots.
Via a Monday Twitter post, President Joe Biden made an unqualified assertion that the experimental coronavirus vaccines, which are not even vaccines under the normal meaning of vaccines, the United States government is encouraging Americans to take are “safe” for everyone. However, taking a look through the fact sheets for recipients and caregivers regarding the Pfizer-BioNTech and Moderna experimental coronavirus vaccines, available at the website of the US government’s Centers for Disease Control and Prevention, you find a very different representation.